Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UV-X System for Corneal Collagen Cross-Linking in Refractory Corneal Infection
NCT02068430Phase 1Completed
- Start
- Nov 2008
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of riboflavin in corneal ulcer. Primary endpoints: Number of patients with healed corneal ulcers at 6 months and Number of adverse events at 6 months. Started Nov 2008; status: completed.
02
Drugs
riboflavin
03
Conditions
corneal ulcer
Beyond the preview
Go deeper on NCT02068430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068430.